Autonomic Pharmacology

Neuromuscular Blockers Practice Questions

20 free Neuromuscular Blockers practice questions for the Pharmacology, each with the correct answer and a detailed explanation. Open any question below, or take the full set as an interactive quiz.

Start Practice Quiz

Questions

All Neuromuscular Blockers questions

20 questions
  1. Q1. Which of the following neuromuscular blocking agents is a depolarizing blocker?
  2. Q2. Neuromuscular blocking drugs primarily act on which type of receptor at the neuromuscular junction?
  3. Q3. Which nondepolarizing neuromuscular blocker undergoes Hofmann elimination for metabolism?
  4. Q4. Which drug is commonly used to reverse the effects of nondepolarizing neuromuscular blockers?
  5. Q5. Which neuromuscular blocking agent is most commonly used for rapid sequence intubation due to its rapid onset and short duration?
  6. Q6. Which enzyme is responsible for the metabolism of succinylcholine in plasma?
  7. Q7. Which adverse effect is most associated with succinylcholine administration?
  8. Q8. Nondepolarizing neuromuscular blockers produce paralysis by which mechanism?
  9. Q9. Which neuromuscular blocker has a prolonged duration of action and significant vagolytic activity?
  10. Q10. Which condition can significantly prolong the effect of succinylcholine?
  11. Q11. Which neuromuscular blocker is associated with histamine release leading to hypotension and bronchospasm?
  12. Q12. Which drug specifically reverses the effects of rocuronium and vecuronium by encapsulation?
  13. Q13. Which neuromuscular blocker is considered an intermediate-acting nondepolarizing agent?
  14. Q14. Which phase of succinylcholine block resembles a nondepolarizing block after prolonged exposure?
  15. Q15. Which neuromuscular blocker produces the least histamine release?
  16. Q16. Which muscle group is typically the first to be paralyzed by neuromuscular blockers?
  17. Q17. Which neuromuscular blocker is safest in patients with severe renal impairment due to organ-independent metabolism?
  18. Q18. Which complication of succinylcholine is particularly associated with patients having major burns or neuromuscular diseases?
  19. Q19. Which agent is most likely to cause malignant hyperthermia in susceptible individuals?
  20. Q20. Which neuromuscular blocker has the fastest onset among nondepolarizing agents and is often used as an alternative to succinylcholine?